For single endpoints including all-cause mortality, CV death, and HF hospitalization, intravenous iron therapy only showed a decreasing trend without reaching statistical significance.
← all excerpts
Intravenous iron therapy for patients with heart failure: a meta-analysis stratified by chronic kidney disease status.
1
—
—